1. Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience. (2nd December 2019) Authors: Djebbari, Faouzi; Hubenov, Huben; Neelakantan, Pratap; Wolf, Julia; Offer, Mark; Khera, Akhil; Louka, Eleni; Vallance, Grant; Kothari, Jaimal; Moore, Sally; Ramasamy, Karthik Journal: British journal of haematology Issue: Volume 188:Number 4(2020) Page Start: e57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience. Issue 6 (12th May 2021) Authors: Maouche, Nadjoua; Kishore, Bhuvan; Jenner, Matthew W.; Boyd, Kevin; Bhatti, Zara; Bird, Sarah Anne; Chander, Gurvin; Robinson, Rebecca; Vallance, Grant D.; Offer, Mark; Kothari, Jaimal; Peniket, Andy; Aitchison, Robin; Dungarwalla, Moez; Collings, Freya; Bygrave, Ceri; Ramasamy, Karthik Journal: Leukemia & lymphoma Issue: Volume 62:Issue 6(2021) Page Start: 1396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗